A new clinical study presented at NUTRITION 2025, the annual meeting of the American Society for Nutrition, has found that daily consumption of chickpeas and black beans may significantly improve cholesterol levels and reduce inflammation markers in individuals with prediabetes — a condition that affects millions worldwide and is considered a precursor to type 2 diabetes.
Researchers conducted a 12-week randomized trial involving 72 participants with prediabetes. Participants were divided into three groups, each consuming one cup daily of either:
Blood samples were collected at the beginning, mid-point (week 6), and end of the study (week 12) to measure key biomarkers such as:
At the 12-week mark, participants who consumed chickpeas showed a significant reduction in total cholesterol, while those who ate black beans daily had notably lower IL-6 levels, indicating reduced inflammation.
Although the white rice group surprisingly showed a reduction in LDL cholesterol, it was the legume-consuming groups that showed the most promising overall metabolic benefits.
Prediabetes affects an estimated 96 million adults in the U.S., according to the CDC. While it does not always progress to type 2 diabetes, it significantly increases the risk. Importantly, prediabetes is reversible, especially through dietary interventions.
This study adds to the growing body of evidence supporting legumes like chickpeas and black beans as powerful tools in managing metabolic health — thanks to their high fiber, protein, and plant-based nutrient content.
Despite their benefits, legume consumption remains low in Western diets, with U.S. adults spending less than $5 annually on them. However, experts stress that there are easy and budget-friendly ways to incorporate beans into your meals:
Registered dietitians also advise people with irritable bowel syndrome (IBS) to gradually introduce legumes and seek personalized guidance due to their fiber content.
CLICK HERE TO FOLLOW the official Medical News Pakistan WhatsApp Channel for real-time updates, expert insights, and exclusive stories that matter to every person.